Skip to main content
    T

    TriSalus Life Sciences Inc. (TLSI)

    Official site

    HEALTHCARE • MEDICAL DEVICES • NASDAQ

    $2.27
    -0.16 (-6.58%)

    Market Cap: $149.93M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    TriSalus Life Sciences Inc. (TLSI) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to TriSalus Life Sciences are Quanterix (QTRX), Standard Biotools (LAB) and Rxsight (RXST). By market cap, TriSalus Life Sciences ranks 5th of the 13 companies on this page; Treace Medical Concepts (TMCI) is the largest at $345.50M.

    Peer Comparison

    TLSI's ROIC of -65.0% is below the peer median of -16.5%, and its revenue growth of 11.3% is above the median of -1.9%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    TriSalus Life Sciences (TLSI)$149.93MN/A2.9x-56.6%-65.0%11.3%0.00%
    Quanterix Corp (QTRX)$139.11MN/A0.9x-75.0%N/A-13.1%0.00%
    Standard Biotools Inc (LAB)$279.27MN/A3.8x157.6%-9.9%-0.9%0.00%
    Rxsight Inc (RXST)$223.06MN/A1.8x-43.8%-23.3%-19.0%0.00%
    Sera Prognostics Inc (SERA)$79.94MN/AN/A0.0%N/A162.5%0.00%
    MaxCyte Inc (MXCT)$122.87MN/A3.6x-114.8%N/A-14.5%0.00%
    QuantumSi Inc (QSI)$252.70MN/A183.5x0.0%N/A-61.6%0.00%
    Neuronetics Inc (STIM)$134.10MN/A0.7x-14.4%-13.3%12.5%0.00%
    LENSAR Inc (LNSR)$61.47MN/A1.1x56.1%142.2%-1.3%0.00%
    Inogen Inc (INGN)$147.95MN/A0.4x-10.0%N/A-2.4%0.00%
    Owlet Inc (OWLT)$100.52MN/A0.9x-8.4%-16.5%29.9%0.00%
    Treace Medical Concepts Inc (TMCI)$345.50MN/A1.4x-27.4%-32.8%-3.9%0.00%
    Nyxoah (NYXH)$91.61MN/A2.6x0.0%-65.9%365.0%0.00%
    Peer median$136.61MN/A1.4x-9.2%-16.5%-1.9%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to TriSalus Life Sciences, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Medical Devices.

    CompanyAboutPeers
    Quanterix Corp (QTRX)
    Quanterix Corporation, a life sciences company, develops and markets digital immunoassay platforms that advance precision health for life sciences research...
    QTRX competitors
    Standard Biotools Inc (LAB)
    Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools...
    LAB competitors
    Rxsight Inc (RXST)
    Rxsight Inc. is a cutting-edge healthcare technology company dedicated to transforming vision correction through advanced diagnostic and surgical solutions...
    RXST competitors
    Sera Prognostics Inc (SERA)
    Sera Prognostics Inc. is a pioneering force in maternal-fetal health, focusing on cutting-edge diagnostic solutions designed to enhance pregnancy outcomes.
    SERA competitors
    MaxCyte Inc (MXCT)
    MaxCyte Inc. (MXCT) is a leader in cell-engineering, renowned for its innovative Flow Electroporation® technology that enables efficient and scalable delivery...
    MXCT competitors
    QuantumSi Inc (QSI)
    Quantum-Si incorporated operates the first next-generation protein sequencing platform for the healthcare industries.
    QSI competitors
    Neuronetics Inc (STIM)
    Neuronetics, Inc., a commercial-stage medical technology company, designs, develops...
    STIM competitors
    LENSAR Inc (LNSR)
    LENSAR, Inc., a commercial stage medical device company, is focused on designing...
    LNSR competitors
    Inogen Inc (INGN)
    Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators for patients, physicians and other physicians...
    INGN competitors
    Owlet Inc (OWLT)
    Owlet Inc. is a leading innovator in infant health technology, dedicated to enhancing the safety and wellness of newborns through its state-of-the-art...
    OWLT competitors
    Treace Medical Concepts Inc (TMCI)
    Treace Medical Concepts, Inc., an orthopedic medical device company, is dedicated to the design, manufacture...
    TMCI competitors
    Nyxoah (NYXH)
    Nyxoah is an innovative medical technology firm dedicated to advancing treatment options for obstructive sleep apnea (OSA) through its proprietary Genio system...
    NYXH competitors

    Frequently Asked Questions About TLSI

    Who are TriSalus Life Sciences' main competitors?

    The companies most similar to TriSalus Life Sciences include Quanterix (QTRX), Standard Biotools (LAB), Rxsight (RXST), Sera Prognostics (SERA) and MaxCyte (MXCT), listed from the closest match.

    Who is TriSalus Life Sciences' biggest competitor?

    Treace Medical Concepts (TMCI) is the largest of the similar companies at $345.50M; Quanterix (QTRX) is the closest match by business profile, size, sector and industry.

    How does TLSI stock compare with its competitors?

    TLSI's P/S is 2.9x against a peer median of 1.4x; its net margin is -56.6% against a peer median of -9.2%.

    Which of TriSalus Life Sciences' competitors pays a higher dividend?

    TriSalus Life Sciences pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is TriSalus Life Sciences bigger than its competitors?

    No. TriSalus Life Sciences is 5th by market cap among the 13 companies on this page; the largest is Treace Medical Concepts (TMCI) at $345.50M.